|
Diagnostics has been viewed as one of the most transactional segments of healthcare for decades.
A customer books a blood test, receives a report, shares it with a doctor, and moves on. The interaction is largely episodic, driven by illness, medical advice, or a specific health concern.
Unlike e-commerce, fintech, or consumer technology businesses where repeat engagement and long-term customer relationships are core business metrics, diagnostics has traditionally not been viewed through the lens of retention.
Most people interacted with diagnostic services only when something went wrong or when a physician recommended testing. The relationship ended once the report was delivered.
What if diagnostics are beginning to evolve from transaction to a long-term consumer behaviour?
That possibility has implications not only for diagnostic providers but for the broader healthcare ecosystem.
From access to engagement
For the better part of the last decade, healthcare innovation in diagnostics has focused on improving access.
Laboratories expanded aggressively into Tier II and Tier III cities. Home sample collection became mainstream. Online booking simplified the testing process. Digital reports eliminated waiting periods and reduced paperwork. Price transparency improved, and consumers gained the ability to compare laboratories before making a decision.
Collectively, these changes have transformed diagnostics into one of the most accessible healthcare services in India.
However, convenience alone cannot explain sustained customer engagement over multiple years.
Consumers rarely return simply because booking is easy. They return because they see ongoing value. That distinction is becoming increasingly important.
A new generation of preventive consumers
One of the biggest changes occurring across healthcare today is the growing shift from reactive care to preventive care.
Consumers are no longer waiting for symptoms before engaging with the healthcare system.
Routine cholesterol monitoring, HbA1c tracking, thyroid testing, vitamin deficiency assessments, liver function tests, kidney function tests, hormone profiling, and preventive health packages are becoming increasingly common even among relatively young and healthy individuals. Several factors are contributing to this shift.
Greater health awareness after the pandemic has encouraged individuals to monitor their health more proactively. Lifestyle diseases such as diabetes, hypertension, obesity, and cardiovascular disorders are affecting people at younger ages. Wearable devices have familiarised consumers with continuous health tracking, making regular monitoring feel increasingly natural. Digital health platforms have also made health information more accessible than ever before.
Taken together, these developments are changing the relationship people have with diagnostics.
Testing is no longer viewed solely as a response to illness. Increasingly, it is becoming part of an ongoing effort to understand, preserve, and improve health. That fundamentally changes consumer behaviour.
Looking beyond acquisition
Healthcare businesses have traditionally been evaluated on their ability to acquire new customers.
How many patients were served?
How many first-time users booked tests?
How effectively can customer acquisition costs be optimised?
These remain important questions. But if customers continue returning well beyond their first year, another metric deserves equal attention.
Retention
Retention reflects something that acquisition alone cannot measure - trust. A customer who returns repeatedly has already evaluated the quality of service, reliability of reports, convenience of sample collection, turnaround time, and overall experience. Each repeat interaction reinforces confidence in the provider.
Over time, diagnostics begins to resemble other industries where long-term customer relationships generate significantly greater value than one-time transactions. This shift also changes how healthcare providers think about engagement.
Success is no longer measured solely by the number of tests performed. It is measured by the continuity of the relationship.
Health data becoming longitudinal
Many customers are comparing current reports with historical ones. They are tracking trends over time rather than focusing on isolated readings. They want to understand whether cholesterol has improved over the last twelve months, whether HbA1c levels are moving in the right direction, whether thyroid medication is working as expected, or whether lifestyle changes are delivering measurable outcomes.
In other words, diagnostic reports are becoming longitudinal records rather than standalone documents. This represents a meaningful change in behaviour.
Health decisions become more informed when viewed through trends rather than individual data points. A single cholesterol reading provides useful information. Five years of cholesterol history provides context. That context is where much of the future value in diagnostics may lie.
The next challenge is not more testing
India has made remarkable progress in expanding diagnostic infrastructure. Laboratories are more sophisticated. Testing capabilities continue to improve. Automation is increasing accuracy and reducing turnaround times. Digital platforms have simplified access.
Yet one major challenge remains
Consumers often struggle to interpret what their reports actually mean. Most individuals receive numbers without sufficient context. Is this result significantly different from last year? Should they be concerned? Which lifestyle changes matter most? When should they test again? How does one report relate to another?
These questions remain largely unanswered once the report is delivered. This stage is where the next phase of diagnostics may emerge.
The industry's future opportunity may not be generating more reports. It may be helping consumers derive greater value from the reports they already possess.
Providing historical comparisons, identifying meaningful trends, simplifying interpretation, and supporting informed conversations with physicians could become increasingly valuable components of the diagnostic experience.
Breaking down healthcare silos
Healthcare has historically suffered from fragmented information. A patient's blood tests may exist in one laboratory. Radiology records in another hospital. Prescriptions with multiple physicians. Health histories spread across different providers. As consumers become increasingly engaged with preventive healthcare, they find this fragmentation more problematic.
People do not simply want isolated reports. They want continuity. They want a consolidated understanding of how their health has evolved. Creating that continuity will require stronger integration across diagnostics, clinical care, digital health platforms, and patient records.
The organisations that successfully connect these fragmented data points may ultimately create significantly greater value than those that focus solely on individual diagnostic transactions.
Technology will accelerate this shift
Artificial intelligence, digital health platforms, and predictive analytics are likely to accelerate this transformation over the coming years.
Rather than simply delivering reports, future diagnostic platforms may help identify patterns, highlight meaningful deviations, generate personalised health summaries, and recommend appropriate follow-up discussions with healthcare professionals.
Importantly, technology should complement and not replace clinical judgement. Its greatest value lies in helping patients and physicians interpret growing volumes of health data more efficiently and consistently.
As individuals generate increasingly rich health histories, intelligent tools can help convert raw information into actionable insights while supporting better-informed medical decisions.
The quiet signals that matter
Some of the most significant industry shifts rarely announce themselves dramatically. They appear quietly in customer behaviour long before they become obvious in market reports.
The growing importance of diagnostic retention feels like one of those early signals. It suggests that consumers are beginning to see diagnostics not as isolated healthcare events but as an integral part of managing their long-term well-being.
If this trend continues, it could reshape how diagnostic businesses measure success, how digital health platforms engage users, and how preventive healthcare is delivered in India. The conversation may gradually shift from individual test bookings to lifetime health journeys. That is a fundamentally different way of thinking about diagnostics.
Looking ahead
India's diagnostics industry stands at an important inflection point. The foundations - lab infrastructure, digital accessibility, home sample collection, and nationwide reach have largely been established. The next phase of growth may depend less on expanding access and more on strengthening engagement.
Consumers increasingly want continuity, context, and clarity and not just test results. They want to understand how their health is changing over time, what those changes mean, and what actions they should consider next in consultation with their healthcare providers.
If that expectation continues to grow, diagnostics will evolve beyond being a service that simply measures health. It will become an ongoing partner in helping individuals manage it.
And if the early retention patterns we are observing continue to strengthen, the future of diagnostics may no longer be defined by one-time test bookings. It will be defined by continuous engagement, longitudinal health insights, and a stronger partnership between consumers and the healthcare ecosystem.
The industry's next chapter may not be about performing more tests. It may be about making every test matter more.
(Author is Founder & CEO of Curelo)
|